Aggribloc Tirofiban Hydrochloride Injection

About Aggribloc Tirofiban Hydrochloride Injection

Aggribloc Tirofiban Hydrochloride Injection is an antiplatelet medication used in the management of acute coronary syndrome (ACS) and during percutaneous coronary intervention (PCI) procedures. It works by inhibiting platelet aggregation, thereby reducing the risk of blood clot formation in coronary arteries.

This injection is widely used in hospital and ICU settings under the supervision of a cardiologist, especially for patients at high risk of thrombotic events.

• Effective platelet aggregation inhibitor

• Helps prevent clot formation in coronary arteries

• Reduces risk of myocardial infarction in ACS patients

• Fast-acting intravenous formulation

• Trusted choice for cardiac emergency management

• Generic Name: Tirofiban Hydrochloride

• Form: Injection

• Administration: Intravenous (IV use only)

• Acute Coronary Syndrome (Unstable Angina / NSTEMI)

• During Percutaneous Coronary Intervention (PCI)

• Prevention of ischemic cardiac complications

Dosage should be administered as prescribed by a qualified healthcare professional. To be used only in a hospital setting.

• Store in a cool, dry place

• Protect from light

• Keep out of reach of children

• For prescription use only

• Not to be self-administered

• Use strictly under medical supervision